Sign In
Buy IDXX
$595.76
+9.09 (+1.55%)
At Close: Aug 10, 2026
IDEXX Laboratories' (IDXX) Management on Q2 2019 Results - Earnings Call Transcript
03:46pm, Thursday, 01'st Aug 2019
IDEXX Laboratories' (IDXX) Management on Q2 2019 Results - Earnings Call Transcript
IDEXX (IDXX) Beats Q2 Earnings Estimates, Lifts EPS Guidance
09:27am, Thursday, 01'st Aug 2019
IDEXX's (IDXX) top line in the second quarter gains from strong sales at the CAG business.
Idexx Laboratories (IDXX) Q2 Earnings Surpass Estimates
07:45am, Thursday, 01'st Aug 2019
Idexx (IDXX) delivered earnings and revenue surprises of 4.38% and -1.25%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Can IDEXX's (IDXX) International Growth Drive Q2 Earnings?
11:12am, Friday, 26'th Jul 2019
In the United States, IDEXX (IDXX) witnesses a strong uptrend in CAG Diagnostic recurring revenues.
Why the Earnings Surprise Streak Could Continue for Idexx (IDXX)
10:10am, Tuesday, 23'rd Jul 2019
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Stocks to Play the Pet Care Trend
12:47pm, Monday, 24'th Jun 2019
With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.
IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength
10:58am, Friday, 21'st Jun 2019
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
Why Is Idexx (IDXX) Up 3% Since Last Earnings Report?
09:31am, Friday, 31'st May 2019
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
08:32am, Wednesday, 29'th May 2019
IDEXX (IDXX) registers strong revenue growth on the back of CAG Diagnostics.
Idexx Labs CEO: Millennials and Pet Care | Mad Money | CNBC
11:51am, Thursday, 23'rd May 2019
Idexx Laboratories CEO Jonathan Ayers chats with Jim Cramer about growing demand for preventative care for dogs and cats, and explains growth prospects for the veterinary diagnostics company.
Moving Average Crossover Alert: IDEXX Laboratories
06:12am, Monday, 06'th May 2019
IDEXX Laboratories is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Rising Margins Allow IDEXX Laboratories to Boost Guidance
04:19pm, Wednesday, 01'st May 2019
Expense control is helping the animal diagnostic company drive double-digit profit growth.
IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q1 2019 Results - Earnings Call Transcript
03:43pm, Wednesday, 01'st May 2019
IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q1 2019 Results - Earnings Call Transcript
Idexx Laboratories (IDXX) Beats Q1 Earnings and Revenue Estimates
01:16pm, Wednesday, 01'st May 2019
Idexx (IDXX) delivered earnings and revenue surprises of 12.50% and 0.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up
11:39am, Wednesday, 01'st May 2019
Strong sales at the CAG business favor IDEXX's (IDXX) top line in Q1.
